Education
1992-1996 B.S., Nanjing University, China
1996-1999 M.S., Shanghai Institute of Biochemistry, Chinese Academy of Sciences, China 2000-2006 Ph.D., Rutgers University, USA
Academic Experience
2007-2011 Postdoctoral Fellow, University of Pennsylvania, USA
2012-2015 Professor, Tongji Medical School, Huazhong University of Science & Technology, China
2016- Professor, Medical Research Institute, Wuhan University, China
Representative Publications
1.Daibiao Xiao, Ming Yue, Hexiu Su, Ping Ren, Jue Jiang, Feng Li, Yufeng Hu, Haining Du, Hudan Liu, Guoliang Qing* (2016). Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feed-Forward Circuit Promoting Tumor Cell Survival. Molecular Cell, 64(3): 493-506.
2. Chen H, Liu H, Qing G* (2018). Targeting oncogenic Myc as a strategy for cancer treatment. Signal Transduction & Targeted Therapy, 3: 5.
3. Yang Dong, Rongfu Tu, Hudan Liu, Guoliang Qing* (2020). Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat. Signal Transduction & Targeted Therapy, 5: 124.
4. Liyuan Wang, Chan Chen, Zeming Song, Honghong Wang, Minghui Ye, Dongghai Wang, Wenqian Kang, Hudan Liu, Guoliang Qing* (2022). EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation. Nature Communications, 13(1):12.
5.Donghai Wang, Zhinan Yin, Honghong Wang, Liyuan Wang, Tao Li, Ruijing Xiao, Ting Xie, Ruyi Han, Rui Dong, Hudan Liu, Kaiwei Liang, Guoliang Qing* (2023). The super elongation complex drives transcriptional addiction in MYCN-amplified neuroblastoma. Science Advances, 9(13): eadf0005.
